ACT-BEZAFIBRATE SR 400 MG
BEZAFIBRATE : 400 MG · DIN 02379414 · ACTAVIS GROUP PTC EHF
Health Canada status: CANCELLED PRE MARKET
What is ACT-BEZAFIBRATE SR?
ACT-BEZAFIBRATE SR 400 MG contains BEZAFIBRATE : 400 MG. It is listed in the Health Canada Drug Product Database under DIN 02379414, held by ACTAVIS GROUP PTC EHF, supplied as TABLET (EXTENDED-RELEASE) for ORAL administration. Health Canada currently lists it as cancelled pre market, status dated 04-Sep-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02379414 |
|---|---|
| Brand name | ACT-BEZAFIBRATE SR |
| Generic / active ingredient | BEZAFIBRATE : 400 MG |
| Manufacturer | ACTAVIS GROUP PTC EHF |
| Strength | 400 MG |
| Dosage form | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C10AB02 BEZAFIBRATE |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 04-Sep-2018 |
| Original market date | 2012-10-03 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code C10AB02 BEZAFIBRATE. 2 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BEZALIP SR | 400 MG | TABLET (EXTENDED-RELEASE) | ALLERGAN INC | MARKETED | DIN 02083523 |
| JAMP-BEZAFIBRATE SR | 400 MG | Tablet | JAMP PHARMA CORPORATION | MARKETED | DIN 02453312 |
| BEZALIP TAB 200MG | 200 MG | TABLET | HOFFMANN-LA ROCHE LIMITED | CANCELLED POST MARKET | DIN 02084082 |
| PMS-BEZAFIBRATE | 200 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02240331 |
Who else supplies BEZAFIBRATE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BEZAFIBRATE appears in 12 registered pack listings across 5 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.